Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well decitabine works in treating patients with
previously untreated acute myeloid leukemia. Drugs used in chemotherapy, such as decitabine,
work in different ways to stop the growth of cancer cells, either by killing the cells or by
stopping them from dividing